Hallucinations in LLMs refer to instances where models generate plausible yet incorrect or unrelated information.
Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...
GlobalData on MSN1d
Acellera and Psivant partner for AI-driven drug discoveryAcellera Therapeutics focuses on drug discovery by merging AI-driven innovation with computational scaleability, aiming to ...
Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...
Hosted on MSN3d
The AI advantage in discovering new medicinesWith continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.
Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.
AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.
DeepSeek-R1 charts a new path for AI through explaining its own reasoning process. Why does this matter and how will it benefit the world?
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...
Manas AI, a full-stack, AI-driven company focused on discovering and advancing next generation medicines, launched today. By leveraging its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback